Pmv Pharmaceuticals Inc (PMVP NASDAQ) stock market data APIs
$0.8767
-0.03(-3.4%)
as of May 9, 2025
Try our APIs with
free plan!
Pmv Pharmaceuticals Inc Financial Data Overview
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Prev. Close
0.8767
Open
0.8448
High
0.9092
Low
0.8448
52 wk Range
0.821-2.23
Market Cap
45 858 K
Shares Outstanding
51 952 K
EPS
-0.34
Beta
1.495
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pmv Pharmaceuticals Inc data using free add-ons & libraries
Get Pmv Pharmaceuticals Inc Fundamental Data
Pmv Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -83 707 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: -0.3833
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pmv Pharmaceuticals Inc News
New
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic t...
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
PMV Pharmaceuticals, Inc. Prioritization of PC14586 development and focused discovery research efforts results in a workforce reduction of approximately 30% Unaudited cash, cash equivalents, and mar...
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
PMV Pharmaceuticals, Inc. PC14586 clinical program to be led by Deepika Jalota, Pharm.D. (Chief Development Officer) and Marc Fellous, M.D. (Senior Vice President, Head of Clinical Development and Me...
PMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updates
PMV Pharmaceuticals Inc (NASDAQ:PMVP) presented updated data from Phase 1 PYNNACLE clinical trial, showing promising responses across multiple tumor types. PMVP reported a net loss of $53.2 million fo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
